Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

patent: 3 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Soluble glycosaminoglycanases and methods of preparing and using soluble…

Grant US-10588983-B2

United States of America

Combinations and methods for subcutaneous administration of immune globulin and…

Grant US-10301376-B2

United States of America

Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof

Grant US-9084743-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.